Diabetes peripheral neuropathy
Conditions
Interventions
Intervention group:Wentong Huoxue Cream+Basic Treatment
Control group:Wen Tong Huo Xue Cream Simulator+Basic Treatment
Sponsors
Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age range from 18 to 75 years old; (2) Patients with type 2 diabetes peripheral neuropathy; (3) Voluntarily participate in this experiment and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Toronto score = 5 points (2) Other neurological disorders, such as cervical or lumbar spondylosis (nerve root compression, spinal stenosis, cervical and lumbar degenerative changes), cerebral infarction, Guillain Barre syndrome, or severe arteriovenous disease (venous thrombosis, lymphangitis) (3) Patients with lower limb skin ulcers or gangrene, moderate to severe edema of the lower limbs, or those with lower limb skin diseases; (4) Acute complications such as diabetes ketoacidosis, hyperglycemia and hypertonic syndrome, diabetes lactic acidosis, and acute gout patients; (5) Patients with malignant tumors or severe heart, liver, and kidney dysfunction; (6) Pregnant or lactating individuals, or those who have planned to conceive within the past year; (7) Participants in other clinical studies within the past three months; (8) Those who cannot understand the nature, scope, and possible outcomes of the research or cannot follow medical advice; (9) Individuals with allergic constitution and a history of drug, food, and contact allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Toronto Clinical Scoring System;VAS ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in nerve electrophysiological conduction velocity;Vibration perception threshold;TCM symptom rating scale;ABI ; | — |
Countries
CNINA
Contacts
Public ContactMA LI
researcher
Outcome results
None listed